Morgan Stanley analyst Kallum Titchmarsh lowered the firm’s price target on Thermo Fisher (TMO) to $620 from $670 and keeps an Overweight rating on the shares. Investors “were clearly looking for more” this quarter, says the analyst, who makes “modest updates” to the firm’s model following the Q1 report in light of guidance.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher to sell microbiology business to Astorg for $1.075B
- Thermo Fisher price target lowered to $600 from $700 at Stifel
- Thermo Fisher price target lowered to $639 from $653 at Baird
- Thermo Fisher Earnings Call Signals Confident Outlook
- Thermo Fisher Scientific: Stock Pullback Seen as Overdone Amid Solid Fundamentals and Second-Half Growth Drivers